Novel Pyridine Compounds
US-2024316020-A1 · Sep 26, 2024 · US
US11723872B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-11723872-B2 |
| Application number | US-201916601270-A |
| Country | US |
| Kind code | B2 |
| Filing date | Oct 14, 2019 |
| Priority date | Nov 15, 2013 |
| Publication date | Aug 15, 2023 |
| Grant date | Aug 15, 2023 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Provided is a rapid release tablet excellent in binding capability and disintegrability and also excellent in storage stability and the like. More specifically, provided are a granulated composite comprising low-substituted hydroxypropyl cellulose having a degree of hydroxypropoxy substitution of from 5 to 16% by weight and D-mannitol, wherein the D-mannitol contains 0.9% by weight or less of D-sorbitol; a rapid release tablet comprising the granulated composite and a drug; and a method for producing a granulated composite comprising the steps of: mixing low-substituted hydroxypropyl cellulose having a degree of hydroxypropoxy substitution of from 5 to 16% by weight, first D-mannitol, and water to obtain an aqueous dispersion, and granulating while adding the aqueous dispersion to second D-mannitol, wherein the first D-mannitol and the second D-mannitol contain 0.9% by weight or less of D-sorbitol in total.
Opening claim text (preview).
The invention claimed is: 1. A rapid release tablet, comprising a drug and a granulated composite comprising low-substituted hydroxypropyl cellulose having a degree of hydroxypropoxy substitution of from 5 to 16% by weight, a first D-mannitol and a second D-mannitol, wherein the granulated composite is not a physical mixture but has a modified surface by granulating while spraying a surface of the second D-mannitol with a homogenous mixture of the low-substituted hydroxypropyl cellulose and the first D-mannitol, an interior of the second D-mannitol not being surface-modified, and wherein the first D-mannitol and the second D-mannitol contain 0.81% by weight or less of D-sorbitol, and disintegration time of the tablet in an oral cavity is less than 30 seconds. 2. The rapid release tablet according to claim 1 , wherein the homogenous mixture further comprises polyvinyl alcohol. 3. The rapid release tablet according to claim 1 , wherein the first D-mannitol is present in the granulated composite in an amount of 5% to 50% by weight with respect to the total amount of D-mannitol.
Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose · CPC title
Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals · CPC title
Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules · CPC title
obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates · CPC title
Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin (homeopathic globules A61K9/1623) · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.